N@N

MYGN, BEAT, SKBI, AIG, BPI. Abnormal Price Friction In Morning Trading Session Today

^{Published on 2009-07-01 08:55:38, Last Modified on 2010-12-22 14:21:38 - WOPRAI}
 

July 1, 2009 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for July 1, 2009. Since late October market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This afair market makinga requirement is designed to prevent market makers from manipulating stock prices. Here is a list of the companies with Abnormal Price Friction (unfair market) in their stock prices in todaya�s trading session. This means that there was more buying than selling in the stocks and their stock prices dropped. Myriad Genetics (NASDAQ: MYGN), CardioNet (NASDAQ: BEAT), Skystar Bio Pharmaceuticals (NASDAQ: SKBI), American International Group (NYSE: AIG) and Bridgepoint Education (NYSE: BPI). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

Symbol Change % BuyVol Buy% SellVol Sell% NetVol Friction

MYGN -$8.69 -24.38% 2,767,453 50.14% 2,593,831 46.99% 173,622 abnormal

BEAT -$6.20 -37.99% 5,059,107 51.69% 4,584,384 46.84% 474,723 abnormal

SKBI -$3.82 -21.29% 226,462 55.73% 178,359 43.89% 48,103 abnormal

DTO -$3.26 -4.38% 179,624 50.96% 171,429 48.64% 8,195 abnormal

AIG -$2.44 -10.52% 6,052,800 38.21% 5,750,846 36.31% 301,954 abnormal

BPI -$0.71 -4.18% 30,993 41.06% 29,586 39.20% 1,407 abnormal

Click here to view chart:

Analysis of the Friction Factor chart above shows that each of the stocks mentioned above had more buying than selling on Wednesday, July 1st, 2009 and their stock prices dropped. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows MYGN with 173,622 greater shares of buying than selling (NetVol) and the stock price is down -$8.69. This means the Market Makers were trading the stock in a way inconsistent with normal supply and demand (Economics 101); more buying than selling should cause prices to rise.

Myriad Genetics, Inc. (NASDAQ: MYGN), a healthcare company, engages in the development and marketing of molecular diagnostic and therapeutic products. Its products include BRACAnalys for assessing a womana�s risk for breast and ovarian cancer; COLARIS molecular for assessing a persona�s risk of developing colorectal cancer or uterine cancer; COLARIS AP, a molecular diagnostic product for colon cancer that detects mutations in the APC and MYH genes; MELARIS, which analyzes mutations in the p16 gene to determine genetic susceptibility to malignant melanoma, a skin cancer; and THERAGUIDE 5-FU that analyzes mutations in the DPYD gene and variations in the TYMS gene to assess patient risk of 5-FU toxicity and guides physician dosing decisions. The company markets its products through its own sales force in the United States and through marketing collaborations internationally. It is also developing Azixa, a phase II drug candidate for solid primary and metastatic brain tumors; Vivecon, a phase I preclinical drug candidate for AIDS; MPC-2130, a phase I drug for hematologic cancers; MPC-3100, a late stage preclinical drug for the treatment of cancer; and MPC-0920, a phase I drug for thrombosis. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.

CardioNet, Inc. (NASDAQ: BEAT) provides ambulatory, continuous, real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual's health in the United States. It offers Mobile Cardiac Outpatient Telemetry (MCOT) device, which incorporates a patient-worn sensor attached to electrodes that capture two-lead electrocardiogram (ECG) data and communicates wirelessly with a compact monitor that analyzes incoming information by applying proprietary algorithms designed to detect arrhythmias and eliminate data noise. Its MCOT device automatically transmits the ECG data to the CardioNet Monitoring Center, when the monitor detects an arrhythmic event. The company also offers Holter monitoring services that store an image of the electrical impulses of every heartbeat or irregularity in either digital format on an internal compact flashcard or in analog format on a standard cassette tape located inside the monitor; and event monitoring services to record and store approximately 540 seconds of ECG signal, as well as pacemaker monitoring services. It markets its arrhythmia monitoring solutions, including the MCOT, primarily to cardiologists and electrophysiologists. The company was incorporated in 1994 and is headquartered in Conshohocken, Pennsylvania.

Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) engages in the development, manufacture, and distribution of medicines, vaccines, and other health care and medical care products for poultry, livestock, and domestic pets in the Peoplea�s Republic of China. The company is headquartered in Xian, the Peoplea�s Republic of China.

American International Group, Inc. (NYSE: AIG), through its subsidiaries, provides insurance and financial services in the United States and internationally. It operates in four segments: General Insurance, Life Insurance and Retirement Services, Financial Services, and Asset Management. The General Insurance segment underwrites various business insurance products, including large commercial or industrial property insurance, excess liability, inland marine, environmental, workersa� compensation, and excess and umbrella coverages. It also offers various specialized forms of insurance, such as aviation, accident and health, equipment breakdown, directors and officers liability, difference-in-conditions, kidnap-ransom, export credit and political risk, and professional errors and omissions coverages. In addition, this segment provides property and casualty reinsurance products to insurers; automobile insurance products; residential mortgage guaranty insurance products; and commercial and consumer lines of insurance products. The Life Insurance and Retirement Services segment offers individual and group life, payout annuities, endowment, and accident and health policies, as well as retirement savings products consisting of fixed and variable annuities. The Financial Services segment provides commercial aircraft and equipment leasing, capital market operations, consumer finance, and insurance premium financing. The Asset Management segment offers investment-related services and investment products to individuals, pension funds, and institutions. The company was founded in 1967 and is based in New York, New York.

Bridgepoint Education, Inc. (NYSE: BPI) provides postsecondary education services. It offers associatea�s, bachelor's, master's, and doctoral programs in the disciplines of business, education, psychology, social sciences, and health sciences. The company offers its programs at campuses located in Clinton, Iowa, and Colorado Springs, Colorado, as well as through online. As of September 30, 2008, it provided 760 courses and 41 degree programs with 37 specializations and 21 concentrations. The company was founded in 1918 and is headquartered in San Diego, California.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2,600,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. None of the companies in this report have paid to be included in this report. From time to time we will mention a company that may have previously paid $995 per month for market data purchased from BUYINS.NET. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

BUYINS.NET, FRICTION FACTOR and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of BUYINS.NET, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting BUYINS.NET or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. BUYINS.NET, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to BUYINS.NET and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State. Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. BUYINS.NET does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. BUYINS.NET places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.BUYINS.net +1-800-715-9999 Tom@buyins.net